166 related articles for article (PubMed ID: 2527399)
1. Use of clodronate and calcitonin in hypercalcemia due to malignancy.
Ljunghall S
Recent Results Cancer Res; 1989; 116():40-5. PubMed ID: 2527399
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of calcitonin and clodronate in hypercalcaemia.
Ljunghall S; Rastad J; Akerström G
Bone; 1987; 8 Suppl 1():S79-83. PubMed ID: 2961359
[TBL] [Abstract][Full Text] [Related]
3. Treatment with clodronate in patients with hypercalcemia secondary to malignancy.
Lind L; Wengle B; Ljunghall S
Ups J Med Sci; 1987; 92(3):259-63. PubMed ID: 2966487
[TBL] [Abstract][Full Text] [Related]
4. Clodronate in hypercalcemia of malignancy.
Bonjour JP; Rizzoli R
Calcif Tissue Int; 1990; 46 Suppl():S20-5. PubMed ID: 2137362
[TBL] [Abstract][Full Text] [Related]
5. Bone and renal components in hypercalcemia of malignancy and responses to a single infusion of clodronate.
Bonjour JP; Philippe J; Guelpa G; Bisetti A; Rizzoli R; Jung A; Rosini S; Kanis JA
Bone; 1988; 9(3):123-30. PubMed ID: 2971382
[TBL] [Abstract][Full Text] [Related]
6. Clodronate. A randomized study in the treatment of cancer-related hypercalcemia.
Witte RS; Koeller J; Davis TE; Benson AB; Durie BG; Lipton A; Stock JL; Citrin DL; Jacobs TP
Arch Intern Med; 1987 May; 147(5):937-9. PubMed ID: 2953318
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hypercalcaemia of malignancy with clodronate.
Bonjour JP; Rizzoli R
Bone; 1991; 12 Suppl 1():S19-23. PubMed ID: 1835397
[TBL] [Abstract][Full Text] [Related]
8. Clodronate treatment in patients with malignancy-associated hypercalcemia.
Rastad J; Benson L; Johansson H; Knuutila M; Pettersson B; Wallfelt C; Akerström G; Ljunghall S
Acta Med Scand; 1987; 221(5):489-94. PubMed ID: 2955674
[TBL] [Abstract][Full Text] [Related]
9. Treatment of the hypercalcaemia of malignancy with intravenous clodronate.
Urwin GH; Yates AJ; Gray RE; Hamdy NA; McCloskey EV; Preston FE; Greaves M; Neil FE; Kanis JA
Bone; 1987; 8 Suppl 1():S43-51. PubMed ID: 2961354
[TBL] [Abstract][Full Text] [Related]
10. Clodronate in the medical management of hyperparathyroidism.
Hamdy NA; Gray RE; McCloskey E; Galloway J; Rattenbury JM; Brown CB; Kanis JA
Bone; 1987; 8 Suppl 1():S69-77. PubMed ID: 2961358
[TBL] [Abstract][Full Text] [Related]
11. Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.
Plosker GL; Goa KL
Drugs; 1994 Jun; 47(6):945-82. PubMed ID: 7521833
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of tumor hypercalcemia with clodronate. Effect on parathormone and calcitriol].
Scharla SH; Minne HW; Sattar P; Mende U; Blind E; Schmidt-Gayk H; Wüster C; Ho T; Ziegler R
Dtsch Med Wochenschr; 1987 Jul; 112(28-29):1121-5. PubMed ID: 2956079
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonate Versus Bisphosphonate and Calcitonin for the Treatment of Moderate to Severe Hypercalcemia of Malignancy.
Khan AA; Gurnani PK; Peksa GD; Whittier WL; DeMott JM
Ann Pharmacother; 2021 Mar; 55(3):277-285. PubMed ID: 32885992
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcemia of malignancy.
Vinholes J; Guo CY; Purohit OP; Eastell R; Coleman RE
J Clin Oncol; 1997 Jan; 15(1):131-8. PubMed ID: 8996134
[TBL] [Abstract][Full Text] [Related]
15. Treatment of malignant hypercalcaemia with clodronate.
Percival RC; Paterson AD; Yates AJ; Beard DJ; Douglas DL; Neal FE; Russell RG; Kanis JA
Br J Cancer; 1985 May; 51(5):665-9. PubMed ID: 3158326
[TBL] [Abstract][Full Text] [Related]
16. Therapy of malignancy-associated hypercalcemia: 1983.
Stewart AF
Am J Med; 1983 Mar; 74(3):475-80. PubMed ID: 6219580
[TBL] [Abstract][Full Text] [Related]
17. Safety of subcutaneous clodronate and efficacy in hypercalcemia of malignancy: a novel route of administration.
Roemer-Bécuwe C; Vigano A; Romano F; Neumann C; Hanson J; Quan HK; Walker P
J Pain Symptom Manage; 2003 Sep; 26(3):843-8. PubMed ID: 12967733
[TBL] [Abstract][Full Text] [Related]
18. Treatment of tumor hypercalcemia with clodronate.
Ziegler R; Scharla SH
Recent Results Cancer Res; 1989; 116():46-53. PubMed ID: 2527400
[TBL] [Abstract][Full Text] [Related]
19. Current and future directions in medical therapy: hypercalcemia.
Body JJ
Cancer; 2000 Jun; 88(12 Suppl):3054-8. PubMed ID: 10898351
[TBL] [Abstract][Full Text] [Related]
20. Treatment of cancer associated hypercalcaemia with combined aminohydroxypropylidene diphosphonate and calcitonin.
Ralston SH; Alzaid AA; Gardner MD; Boyle IT
Br Med J (Clin Res Ed); 1986 Jun; 292(6535):1549-50. PubMed ID: 3087513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
